PRINCIPAL GLOBAL INVESTORS

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

November 13, 2024

Accession Number

0001085146-24-005627

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →